Exercise, Insulin Pumps, and Hypoglycemia—A Practical Framework for Type 1 Diabetes
Exercise is a leading cause of hypoglycemia in people with type 1 diabetes using insulin pumps and AID systems. Learn evidence-based strategies for pre-, during-, and post-exercise insulin adjustments to reduce risk and support safe, confident movement.
When Glucose Isn’t the Villain: Rethinking Euglycemic DKA Management in the Age of Continuous Ketone Monitoring
Euglycemic DKA is often missed because glucose appears normal, but emerging evidence shows it requires more insulin, more dextrose, and tighter ketone-based monitoring. Learn how fixed-rate insulin, higher-concentration dextrose, and continuous ketone monitoring (CKM) are reshaping EDKA management.
Recognizing and Managing Disordered Eating in Diabetes: What Clinicians Need to Know
Learn how to identify and manage disordered eating in type 1 and type 2 diabetes using ADA-recommended screening tools and multidisciplinary care strategies.
Leveling Up with Incretin Therapy: Expanding Benefits Beyond Diabetes, MACE, and Kidneys
Discover how GLP-1 receptor agonists like Semaglutide and Tirzepatide go beyond diabetes care—reducing sleep apnea severity, improving heart and kidney health, easing joint pain, and boosting endurance.
SGLT2 Inhibitors in Type 1 Diabetes – Where Do We Stand in 2025?
SGLT2 inhibitors have dramatically advanced the management of type 2 diabetes by reducing glycemia, cardiovascular events, and renal disease progression.